BCL2 and ovarian cancer: Terminal node 1 was defined as individuals carrying the homozygous variant genotypes (VV) for rs11152377 of BCL-2, following by the homozygous wildtype (WW) for rs2889 of TNFRSF10B, which had the lowest ovarian cancer risk as the reference node.